Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.
Henjum K, Almdahl IS, Årskog V, Minthon L, Hansson O, Fladby T, Nilsson LN. Henjum K, et al. Among authors: fladby t. Alzheimers Res Ther. 2016 Apr 27;8(1):17. doi: 10.1186/s13195-016-0182-1. Alzheimers Res Ther. 2016. PMID: 27121148 Free PMC article.
CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.
Fjell AM, Amlien IK, Westlye LT, Stenset V, Fladby T, Skinningsrud A, Eilsertsen DE, Bjørnerud A, Walhovd KB. Fjell AM, et al. Among authors: fladby t. Neuroimage. 2010 Jan 15;49(2):1820-30. doi: 10.1016/j.neuroimage.2009.09.029. Epub 2009 Sep 30. Neuroimage. 2010. PMID: 19800012
Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease.
Chalbot S, Zetterberg H, Blennow K, Fladby T, Andreasen N, Grundke-Iqbal I, Iqbal K. Chalbot S, et al. Among authors: fladby t. J Alzheimers Dis. 2011;25(3):505-15. doi: 10.3233/JAD-2011-101959. J Alzheimers Dis. 2011. PMID: 21471645 Free PMC article.
Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment.
Selnes P, Aarsland D, Bjørnerud A, Gjerstad L, Wallin A, Hessen E, Reinvang I, Grambaite R, Auning E, Kjærvik VK, Due-Tønnessen P, Stenset V, Fladby T. Selnes P, et al. Among authors: fladby t. J Alzheimers Dis. 2013;33(3):723-36. doi: 10.3233/JAD-2012-121603. J Alzheimers Dis. 2013. PMID: 23186987 Free article.
First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study.
Andreasen N, Simeoni M, Ostlund H, Lisjo PI, Fladby T, Loercher AE, Byrne GJ, Murray F, Scott-Stevens PT, Wallin A, Zhang YY, Bronge LH, Zetterberg H, Nordberg AK, Yeo AJ, Khan SA, Hilpert J, Mistry PC. Andreasen N, et al. Among authors: fladby t. PLoS One. 2015 Mar 19;10(3):e0098153. doi: 10.1371/journal.pone.0098153. eCollection 2015. PLoS One. 2015. PMID: 25789616 Free PMC article. Clinical Trial.
153 results